Acclarent's Series C brings in $35mm
Acclarent (surgical device for ENT indications) raised $35mm through its Series C private financing round. New investors Meritech Capital Partners (lead) and Delphi Ventures were joined by existing backers New Enterprise Associates and Versant Ventures. Individual investors also participated.
- Medical Devices
- Surgical Equipment & Devices
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.